Theoretical and Natural Science
- The Open Access Proceedings Series for Conferences
Theoretical and Natural Science
Vol. 33, 08 March 2024
Open
Access | Article
The mechanism and efficiency of mRNA-based dendritic cell immunotherapy
* Author to whom correspondence should be addressed.
Abstract
In the recent years, the mentions of immunotherapy has become more and more frequent. What emerged along with it are the various types of immunotherapies. This essay includes an introduction to cancer and tumor with the definition, epidemiology, etiology, statistics such as curability regarding types, gender, and race and typical treatments of cancer along with how the immune system functions when targeting tumor cells and how they could potentially disfunction when deceived by tumor cells for example through immune editing. Then, leading on to the main topic to this recent and innovative treatment— immunotherapy. This essay emphasizes on two different types of immunotherapy which are dendritic cell therapy, and messenger RNA vaccine discussing their mechanism as separate treatments. Afterwards, I’ll proceed to discuss the combination of the two which is known as dendritic cell based mRNA vaccine which is a form of mRNA vaccine and it’s own mechanism, advantages, efficiency and current limitations in the conclusion.
Keywords
Cancer, immunotherapy, dendritic cells, mRNA vaccine
References
1. Stoppler, Melissa C. "Why Is Breast Cancer More Common in Females Than Males ? "MedicineNet, 10 May 2017, www.medicinenet.com/breast_cancer_in_males_and_ females/ask.htm. Accessed 20 Sept. 2023.
2. Komen, Susan G. "Race and Ethnicity." Susan G. Komen®, 27 July 2022, www.komen.org/breast-cancer/risk-factor/race-ethnicity/. Accessed 20 Sept. 2023.
3. Taylor, Ashley P. "The 10 Deadliest Cancers, and Why There's No Cure." Livescience.com, 21 Sept. 2022, www.livescience.com/11041-10-deadliest-cancers-cure.html. Accessed 20 Sept. 2023.
4. Sabado, Rachel et al, Dendritic cell-based immunotherapy, nature, Cell Research (2016) 1-22, Doi: 10.1038/cr.2016.157. last accessed 20 AUGUST. 2023
5. Lorentzen, Cathrine Lund et al, Clinical advances and ongoing trials of mRNA vaccines for cancer treatment, Lancet oncology, October 7, 2022 Doi: 10.1016/S1470-2045(22)00372-2. Last accessed 20 AUGUST. 2023
6. Gilboa, Eli et al, immunotherapy of cancer with dendritic-cell-based vaccines, cancer immune immunother (1998)45:82-87, Doi: 10.1007/s002620050465 last accessed 20 September. 2023
Data Availability
The datasets used and/or analyzed during the current study will be available from the authors upon reasonable request.
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. Authors who publish this series agree to the following terms:
1. Authors retain copyright and grant the series right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this series.
2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the series's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this series.
3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See Open Access Instruction).
- Volume Title
- Proceedings of the 2nd International Conference on Modern Medicine and Global Health
- ISBN (Print)
- 978-1-83558-323-4
- ISBN (Online)
- 978-1-83558-324-1
- Published Date
- 08 March 2024
- Series
- Theoretical and Natural Science
- ISSN (Print)
- 2753-8818
- ISSN (Online)
- 2753-8826
- DOI
- 10.54254/2753-8818/33/20240543
- Copyright
- 08 March 2024
- Open Access
- This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited